Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2018-03-29 2018-03-29
Drug Identification Number 02217422 02217422
Brand name MEPRON MEPRON
Common or Proper name Atovaquone Oral Suspension Atovaquone Oral Suspension
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients ATOVAQUONE ATOVAQUONE
Strength(s) 750MG 750MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL
Packaging size 210 mL 210 mL
ATC code P01AX P01AX
ATC description AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS. AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-05 2018-03-05
Estimated end date 2018-05-07 2018-05-07
Actual end date 2018-03-28 2018-03-28
Shortage status Resolved Resolved
Company comments For emergency supply, contact GSK Customer Service 1-800-387-7374. For emergency supply, contact GSK Customer Service 1-800-387-7374.
Health Canada comments